CaMK II expression was evaluated using both Western blot assay and RT-PCR assay (n=32). (A) Western blot assay and statistical analysis for CaMK II expression. (B) Statistical analysis for CaMK II mRNA expression. * P<0.05 vs. Control group, # P<0.05 vs. SCD group. 14N (28N), 14S (28S), and 14L (28L) represent the Control group, SCD group, and SCD+LEV group at 14 day (28 days) after intragastric administration, respectively. Dose of VPA: 150 mg/kg/d.